Annovis Bio Inc expected to post a loss of 40 cents a share - Earnings Preview
Annovis Bio Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
U.S. STOCKS ON THE MOVE-TransMedics, Centrus Energy, MongoDB
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, UnitedHealth, Wells Fargo
Annovis Bio Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Annovis Provides Corporate Updates And Reports First Quarter 2025 Financial Results
Annovis Bio Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Annovis Bio Appoints Hui Liu As Director Of Biostatistics
Brief: Annovis Bio Announces Closing Of $21 Million Public Offering
U.S. STOCKS ON THE MOVE-Becton Dickinson, Tyson Foods, IDEXX Lab
U.S. STOCKS ON THE MOVE-General Motors, Alibaba.com, Annovis Bio
Annovis Bio slides after $21 mln stock offering
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
Annovis Bio rises as FDA approves late-stage Alzheimer's study protocol
Brief: FDA Accepts Final Protocol For Pivotal Phase 3 Alzheimer’S Disease Study, Streamlining Development Pathway
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM
U.S. STOCKS ON THE MOVE-Candel Therapeutics, Broadcom, Reddit